SuperworthBicycle Therapeutics market cap BCYC
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $248.5M
- Highest close in our data
- $1.9B
- Oct 2024
Bicycle Therapeutics is worth $248.5M at the close on Oct 23, 2026, at $3.55 a share.
That is down 55% over the last year and down 81% over five years.
Its highest close in our data was $1.9B in Oct 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $248.5M | $236.6M | $482.1M | −47% |
| 2025 | $473.1M | $438.4M | $1B | −53% |
| 2024 | $1B | $717.3M | $1.9B | +31% |
| 2023 | $767M | $563.8M | $972.1M | −13% |
| 2022 | $878.8M | $403.2M | $1.5B | −51% |
| 2021 | $1.8B | $418.9M | $1.8B | +368% |
| 2020 | $382.4M | $177.8M | $439.5M | +136% |
| 2019 | $162.4M | $121.4M | $205.9M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Bicycle Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| BCYCBicycle Therapeutics | $248.5M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| Peer median | $570.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Bicycle Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.